185 related articles for article (PubMed ID: 24214983)
1. A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
Temme S; Zacharias M; Neumann J; Wohlfromm S; König A; Temme N; Springer S; Trowsdale J; Koch N
J Biol Chem; 2014 Jan; 289(2):639-53. PubMed ID: 24214983
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometry of HLA class II-invariant chain oligomers.
Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
[TBL] [Abstract][Full Text] [Related]
3. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
Neumann J; Koch N
J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
[TBL] [Abstract][Full Text] [Related]
4. Assembly, Intracellular Transport, and Release of MHC Class II Peptide Receptors.
Temme S; Temme N; Koch N
Methods Mol Biol; 2019; 1988():297-314. PubMed ID: 31147949
[TBL] [Abstract][Full Text] [Related]
5. Assembly of major histocompatibility complex class II subunits with invariant chain.
Neumann J; Koch N
FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules.
Karp DR; Teletski CL; Jaraquemada D; Maloy WL; Coligan JE; Long EO
J Exp Med; 1990 Mar; 171(3):615-28. PubMed ID: 2307929
[TBL] [Abstract][Full Text] [Related]
7. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.
Sievers E; Neumann J; Raftery M; SchOnrich G; Eis-Hübinger AM; Koch N
Immunology; 2002 Sep; 107(1):129-35. PubMed ID: 12225371
[TBL] [Abstract][Full Text] [Related]
9. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP
Anczurowski M; Yamashita Y; Nakatsugawa M; Ochi T; Kagoya Y; Guo T; Wang CH; Rahman MA; Saso K; Butler MO; Hirano N
Sci Rep; 2018 Mar; 8(1):4804. PubMed ID: 29555965
[TBL] [Abstract][Full Text] [Related]
11. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi's disease).
Tanaka T; Ohmori M; Yasunaga S; Ohshima K; Kikuchi M; Sasazuki T
Tissue Antigens; 1999 Sep; 54(3):246-53. PubMed ID: 10519361
[TBL] [Abstract][Full Text] [Related]
12. Impact of a truncated invariant chain on in vitro assembly of class II MHC molecules depends on the affinity of invariant chain for a given alpha beta dimer.
Han R
Immunol Invest; 1997 Jun; 26(4):421-37. PubMed ID: 9246563
[TBL] [Abstract][Full Text] [Related]
13. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
Carstens C; Newman DK; Bohlen H; König A; Koch N
Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
[TBL] [Abstract][Full Text] [Related]
14. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
15. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.
Lauterbach N; Crivello P; Wieten L; Zito L; Groeneweg M; Voorter CE; Fleischhauer K; Tilanus MG
Mol Immunol; 2014 May; 59(1):19-29. PubMed ID: 24462895
[TBL] [Abstract][Full Text] [Related]
16. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain.
Triantafilou K; Triantafilou M; Wilson KM; Cherry RJ; Fernandez N
Hum Immunol; 1999 Nov; 60(11):1101-12. PubMed ID: 10600008
[TBL] [Abstract][Full Text] [Related]
17. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
[TBL] [Abstract][Full Text] [Related]
18. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into human MHC-II association with invariant chain.
Wang N; Waghray D; Caveney NA; Jude KM; Garcia KC
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2403031121. PubMed ID: 38687785
[TBL] [Abstract][Full Text] [Related]
20. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
